William J Murphy

19PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsInnate immunityMedical virologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 07, 2026
Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.

|Jul 23, 2026
Intrinsic tumor cell line immunogenicity may drive CAR-independent T cell responses and confound CAR T cell preclinical modeling.

|Jan 31, 2025
What's in a name? Memory NK cells for cancer immunotherapy.

Sean J Judge, Megan C Purl, William J Murphy

|Apr 17, 2024
Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.

Aryana M Razmara, Lauren E Farley, Rayna M Harris

|Sep 01, 2023
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial.

Arta M Monjazeb, Megan E Daly, Guillaume Luxardi

|May 05, 2023
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironment.

Pengfei Xu, Joy C Yang, Bo Chen

Pageof 4

Frequent Collaborators

9 joint publications

Robert J Canter

3 joint publications

Cordelia Dunai

3 joint publications

Robert B Rebhun

3 joint publications

Bruce R Blazar